Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0000905148-26-001862

Chief Financial Officer sold 7,842 shares at $5.18 ($40,658)

From the SEC's structured data for this filing

Trades in this filing

Gagnon Robert E. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-23 Sale : show line 1 in the form −7,842 $5.18 $40,658 592,158 D
Open-market sales · 7,842 sh · avg $5.18 · $40,658
Loading xslF345X06/form4.xml…